On the other hand, upregulation of inflammatory mediators of COX-2, iNOS, and TNF-α reported in the course of diabetic neuropathy, blocking of these mediators lead to a marked reduction in pain intensity [43]. This evidence concerns the gene NOS2 and diabetic neuropathy.